Anest. intenziv. Med. 2019;30(3-4):153-161

Basic neuromodulation methods in chronic pain managementLéčba bolesti - přehledový článek

J. Kozák1,*, Š. Kozák2, I. Vrba3
1 Centrum pro léčení a výzkum bolestivých stavů při Klinice rehabilitace a tělovýchovného lékařství, 2. lékařská fakulta Univerzity Karlovy a Fakultní nemocnice v Motole
2 Ambulance léčby bolesti, Klinika anesteziologie a resuscitace, 3. lékařská fakulta Univerzity Karlovy a Fakultní nemocnice Královské Vinohrady
3 Anesteziologicko-resuscitační oddělení, Nemocnice Na Homolce

Chronic pain is not always manageable with standard treatment modalities. Moreover, physicians are now globally on the constant lookout for opioid sparing in chronic pain management due to the "opioid crisis", and neuromodulation treatment may by the possible answer. Neuromodulation is the process of inhibition, stimulation, modification or therapeutic alteration of activity in the central or peripheral nerve systems, with the use of electric current or drugs. The most important parts of neuromodulation for pain management are neurostimulation and intrathecal drug delivery. The use of neuromodulation has evidently seen growth over the course of the last decade due to novel systems, hardware advancements, and novel chronic pain indications. In this article we present an updated review on spinal cord stimulation and intrathecal drug delivery systems, and their use in chronic pain treatment.

Keywords: chronic pain; treatment; neuromodulation; spinal cord stimulation; intrathecal drug delivery

Received: August 16, 2019; Accepted: September 19, 2019; Published: June 1, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kozák J, Kozák Š, Vrba I. Basic neuromodulation methods in chronic pain management. Anest. intenziv. Med. 2019;30(3-4):153-161.
Download citation

References

  1. Deer TR, Jain S, Hunter C, Chkravarthy K. Neurostimulation for intractable chronic pain. Brain Sci. 2019;9:art. 23. Go to original source... Go to PubMed...
  2. Kozák J, Vrba I, Masopust V, et al. Neuromodulace v léčbě chronické bolesti. In: Bolest. Kršiak M, Kozák J, Rokyta R, eds. Praha: Tigis, 2012:595-621.
  3. Vrba I, Chrobok J, Štětkářová. Typy bolesti a jejich léčba: Failed back surgery syndrome. In: Rokyta R, Kršiak M, Kozák J. Bolest: Monografie algeziologie. 2. vyd. Praha: Tigis, 2012:299-306.
  4. Deer TR, Hayek SM, Pope JE, et al. The Polyanalgesic Consensus Conference (PACC): Recommendations for Trialing of Intrathecal Drug Delivery Infusion Therapy. Neuromodulation. 2017;20:133-154. Go to original source... Go to PubMed...
  5. Gharibo Ch, Laux G, Forzani BR, et al. State of the field survey: Spinal cord stimulator use by academic pain medicine practices. Pain Med. 2014;15:188-195. Go to original source... Go to PubMed...
  6. Russo M, Van-Buyten JP. 10-kHz-frequency SCS therapy: A clinical summary. Pain Med. 2015;16:934-942. Go to original source... Go to PubMed...
  7. Chakravarthy K, Richter H, Christo PJ, et al. Spinal cord stimulation for treating chronic pain: Rewiewing preclinical and clinical data on paresthesia-free high frequency therapy. euromodulation. 2018;21:18-10. Go to original source... Go to PubMed...
  8. Trentman TR, Zimmerman RS, Dodick DW. Occipital nerve stimulation: technical and surgical aspects of implantation. In: Peripheral Nerve Stimulation. Slavin KV, ed. Chicago, III: Karger, 2011:96-108. Go to original source...
  9. Vrba I, Kozák J. Neurostimulace v léčbě ischemických bolestí typu anginy pectoris. In: Houdek M, a kol. Neuromodulace. Praha: Grada Publishing, 2007:131-142.
  10. Osenbach RK, Haines SJ. Spinal cord stimululation for the treatment of refractory angina pectoris. Crit Rev Neurosurg. 2000;9:394-406. Go to original source...
  11. Kapural L, Sessler D, Tluczek H, Nagem H. Spinal Cord Stimu-lation for visceral abdominal pain. Pain Med. 2010;11:347-355. Go to original source... Go to PubMed...
  12. Derbyshire SW. Imaging visceral pain. Curr Pain Headache Rep. 2007;11:178-182. Go to original source... Go to PubMed...
  13. Andres JD, Perotti L, Villaneuva-Perez V, Sensio-Samper JM, Fabregat-Cid G. Role of lumbosacral retrograde neuromodulation in the treatment of painful disorders. Pain Phys. 2013;16:145-153. Go to original source...
  14. Ševčík P. Implantabilní infuzní pumpy. Houdek M, a kol. Neuromodulace. Praha: Grada Publishing, 2007:229-232.
  15. Bolash R, Mekhail N. Intrathecal Pain Pumps - Indications, Patient Selection, Techniques, and Outcomes. Neurosurg Clin N Am. 2014;25:735-742. Go to original source... Go to PubMed...
  16. Vrba I, Kozák J. Failed back surgery syndrome a neuromodulační léčba. Bolest. 2005;8:144-151.
  17. Deer TR, Prager J, Lev R, et al. Polyanalgesic Consensus Conference - 2012: Recommendations to reduce morbidity and mortality in intrathecal drug delivery in the treatment of chronic pain. Neuromodulation. 2012;5:467-482b. Go to original source... Go to PubMed...
  18. Adler JA, Lotz NM. Intrathecal pain management: a team-based approach. J Pain Res. 2017:10:2565-2575. Go to original source... Go to PubMed...
  19. Deer TR, Pope JE, Hayek SM, et al. The Polyanalgesic Consensus Conference (PACC): Recommendations on intrathecal drug infusion systems best practices and guidelines. Neuromodulation. 2017;20:96-132. Go to original source... Go to PubMed...
  20. Wunkelmüller W, Burchiel K, Van Buyten JP. Intrathecal opioid therapy for pain: Efficacy and outcomes. Neuromodulation. 1999;2:67-76. Go to original source... Go to PubMed...
  21. Erdine S, De Andrés J. Drug delivery systems. Pain Pract. 2006;6:1-7. Go to original source... Go to PubMed...
  22. Aló KM. Continuus intrathecal drug administartion trial method for complex benign pain: failed back surgery syndrome. J Pain Symptom Manag. 2000;20:41-50.
  23. Dario A, Scamoni C, Picano M, et al. The infection risk of intrathecal drug infusion pumps after multiple refill procedures. Neuromodulation. 2005;8:36-39. Go to original source... Go to PubMed...




Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.